Drugs / Curcumol
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00542711 | — | — | Hadassah Medical Organization | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Curcumol | “new liquid tumeric/curcumin extract, Curcumol (patent pending, Israel Patent Application No. 181,121)” NCT00542711 ↗ |